Lumasiran Disease Interactions
There are 2 disease interactions with lumasiran.
Lumasiran (applies to lumasiran) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Lumasiran has not been studied in patients with severe liver dysfunction (total bilirubin greater than 3 times the upper limit of normal [3 x ULN] with any AST). No dose adjustment is recommended for patients with mild (total bilirubin greater than 1 to 1.5 x ULN or AST greater than 1 x ULN) or moderate (total bilirubin greater than 1.5 to 3 x ULN with any AST) liver dysfunction.
Lumasiran (applies to lumasiran) renal dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: peritoneal dialysis
Lumasiran has not been studied in patients on peritoneal dialysis. No dose adjustment is needed in patients with renal dysfunction, including patients with renal failure treated with hemodialysis.
Switch to professional interaction data
Report options
More about lumasiran
- lumasiran consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
